Metastatic Spine Tumor clinical trials at UC Cancer
1 research study open to eligible people
open to eligible people ages 18 years and up
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Our lead scientists for Metastatic Spine Tumor research studies include Dean Chou, MD.